Successful Treatment of Refractory Ascites after Liver Transplantation with Splenic Artery Embolization

2012 ◽  
Vol 107 ◽  
pp. S428
Author(s):  
Gaurav Syal ◽  
Neelima Velchala ◽  
Nicholas Brewer ◽  
Michael Beheshti ◽  
Farshad Aduli
HPB ◽  
2018 ◽  
Vol 20 ◽  
pp. S794
Author(s):  
O.A. Nutu ◽  
M. García-Conde Delgado ◽  
I. Justo Alonso ◽  
A.A. Marcacuzco Quinto ◽  
Ó. Caso Maestro ◽  
...  

2021 ◽  
Vol 36 (2) ◽  
pp. 187-192
Author(s):  
Hyung Hwan Moon

Refractory ascites is a rare complication after liver transplantation, and its incidence ranges from 5% to 7%. A 56-yearold man diagnosed with HBV-LC with massive ascites underwent living donor liver transplantation. After transplantation, more than 1000 ml/day of ascites was steadily drained until two weeks after LT. CT showed intrahepatic Rt. portal vein thrombosis and many remnant collaterals with splenomegaly. We decided to embolize the proximal splenic artery and use apixaban to reduce portal flow and resolve the intrahepatic portal thrombosis. One day after splenic artery embolization, the patient's ascites dramatically decreased. Three days later, he was discharged from the hospital. Three months later, a follow-up liver CT showed resolution of thrombosis and no ascites. Splenic artery embolization was an effective and safe procedure for portal flow modulation in portal hyertension. Apixaban was effective for partial portal vein thrombosis in a liver transplant recipient.


2016 ◽  
Vol 3 (2) ◽  
pp. 136-138 ◽  
Author(s):  
Alireza Meighani ◽  
Syed-Mohammed R. Jafri ◽  
Mohammad Raoufi ◽  
Reena Salgia

2011 ◽  
Vol 17 (6) ◽  
pp. 668-673 ◽  
Author(s):  
Cristiano Quintini ◽  
Giuseppe D'Amico ◽  
Chase Brown ◽  
Federico Aucejo ◽  
Koji Hashimoto ◽  
...  

2007 ◽  
Vol 13 (11) ◽  
pp. 1532-1537 ◽  
Author(s):  
Charissa Y. Chang ◽  
Ashwani K. Singal ◽  
Sri V. Ganeshan ◽  
Thomas D. Schiano ◽  
Robert Lookstein ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document